- A new Immunotherapy drug for Acute Lymphoblastic Leukemia (ALL): Blincyto. Approved in December 2014 by the FDA. By Ayguen Sahin, MSc, PhD and Jenna Newman | Cancer Research Simplified
- Cancer in Pets. Guest Post by Professor Seckin Serdar Arun, DVM, PhD, Istanbul University, Veterinary Faculty, Department of Pathology
- Cancer Phobia. Why are we so afraid of cancer? By Anna Faustova, Clinical Psychologist | Cancer Research Simplified
Editor in Chief: Ayguen Sahin, MSc, PhD
Associate Layout Designer: Ms. Zeynep Guler English Editor: Elif Irtemcelik, M.Ed., CAGS |
German Translators: Mr. Frank Rosenbauer, Simone Kuehnle, PhD
Turkish Translators: Tugce Tunalilar, Elif Irtemcelik, M.Ed., CAGS |
Please share this link with your network, family members, friends, colleagues, students, and everyone else whom you think would like to learn more about all aspects of cancer in a simplified, non-technical way. Remember, our mission is: Cancer Education for Allâ„¢
#Cancer #CancerJournal #TheJournalofSimplifiedCancerResearch #JSCR #CancerInPets #PetsAndCancer #Pets #health #CancerPhobia #Immunotherapy #ALL #AcuteLymphoblasticLeukemia #Blincyto #Leukemia #CancerEducation #cancersimplified